Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Kathryn C Zoon

Director at Emergent BioSolutions Inc. (EBS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $144K

Reported trades

Filed Stock Type Shares Price Value Since
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 16,14580,998 held (−17%) $8.36 $135K -23.7%
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 1,05779,941 held (−1%) $8.97 $9K -28.9%
  • Sell

    Director Kathryn C Zoon sold $135K of EBS at $8.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Kathryn C Zoon sold $9K of EBS at $8.97 — pre-scheduled 10b5-1 plan sale.